Last €5.68 EUR
Change Today -0.11 / -1.90%
Volume 112.0
ALINS On Other Exchanges
Symbol
Exchange
EN Paris
As of 3:26 AM 06/20/13 All times are local (Market data is delayed by at least 15 minutes).

intrasense sas (ALINS) Snapshot

Open
€5.79
Previous Close
€5.79
Day High
€5.79
Day Low
€5.68
52 Week High
08/28/12 - €7.65
52 Week Low
01/14/13 - €4.90
Market Cap
17.7M
Average Volume 10 Days
1.4K
EPS TTM
--
Shares Outstanding
3.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INTRASENSE SAS (ALINS)

Related News

No related news articles were found.

intrasense sas (ALINS) Related Businessweek News

No Related Businessweek News Found

intrasense sas (ALINS) Details

Intrasense SAS develops and markets Myrian, a multimodality software platform for the review and analysis of medical images in 3D and 4D to improve diagnostic accuracy, enhance patient management, monitor pathologies, and asses imaging endpoints for clinical trials. It offers Myrian Pro for reading patient CDs, MPR reconstruction, slice thickening, side-by-side comparison, image scrapbook, import, export, print-out, RD burning; and Myrian Advance, a diagnostic workstation in the inmrpretation room, at medical staff meetings, as an add-on to server at the practice, as an extension to PACS, and carried around on laptop. The company also provides Myrian Expert for highlighting specific pathologies; setting lesions in their specific anatomical context; and facilitating communication with clinicians, specialists, and patients. In addition, Intrasense SAS offers for routine diagnosis, surgical planning, oncology, and research; expert, excellence, and external modules; and oncology follow-ups, specialized platforms, clinical trials, OEM solutions, and certifications and DICOM. Further, the company provides guarantee, maintenance, installation, integration, and training services. It sells its products through a distribution network in France, Brazil, the Russian Federation, India, and China; and through agents in Sao Paolo, Berlin, Kuala Lumpur, and Tokyo. Intrasense SAS was founded in 2004 and is headquartered in Montpellier, France.

41 Employees
Last Reported Date: 04/30/12
Founded in 2004

intrasense sas (ALINS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

intrasense sas (ALINS) Key Developments

Intrasense SAS Wins Contract to Equip 15 Hospitals in the United States for Clinical Study

Intrasense SAS announced that it would fit its platform in 15 hospitals in the USA as part of a clinical trial conducted by a new client. Intrasense has sold its Myrian(R) XP-Lung module, which excels at detecting respiratory pathologies, to a manufacturer of medical devices based in the United States, which is currently conducting a clinical trial subject to approval by the FDA. Myrian(R) XP-Lung was selected pursuant to an invitation to tender to standardize the assessment of the criteria for inclusion of patients at the 15 investigating centers that are taking part in this clinical trial.

Intrasense SAS Presents at Gilbert Dupont 10th Health Midcaps Forum, Jun-12-2012

Intrasense SAS Presents at Gilbert Dupont 10th Health Midcaps Forum, Jun-12-2012 . Venue: Monceau Rio - Park Monceau, Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALINS:FP €5.68 EUR -0.11

ALINS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ALINS.
View Industry Companies
 

Industry Analysis

ALINS

Industry Average

Valuation ALINS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.0x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTRASENSE SAS, please visit www.intrasense.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.